2024 C2D2 Symposium Speaker Evaluations

For each speaker, please score your overall impression of their presentation and handling of questions on a scale of 1-20.

Here is a rough scale.

1 - Speaker was unprepared and disorganized.

10 - OK, but could use some work.

15 - Good! Engaging. Clear message. Well-time.

20 - Amazing! Really couldn't be any better.

Question Title

* 1. Jenny Zhe Liao: Cdk8/CDK19 promotes mitochondrial fission through Drp1 phosphorylation and can phenotypically suppress pink1 deficiency in Drosophila

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 2. Please feel free to provide constructive comments for Jenny

Question Title

* 3. Shefali Vishwakarma : A platform for predicting pathogenicity of neuronal Kv7.5 K+ channel variants

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 4. Please feel free to provide constructive comments to Shefali

Question Title

* 5. Shaianne Stein: Generating human biomimetic extracellular matrices for in vitro function studies using mesenchymal stromal cells

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 6. Please feel free to provide constructive comments for Shainanne

Question Title

* 7. Tong Tong Wu: Regulation of Complement Component Synthesis by Mesenchymal Stromal Cells: Insights into Anatomical Imprinting

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 8. Please feel free to provide constructive comments to Tong Tong

Question Title

* 9. Moses Jeong: Kinetic modelling of leucine-mediated signalling and protein synthesis in insulin-resistant human skeletal muscle

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 10. Please feel free to provide constructive comments to Moses

Question Title

* 11. Lionel Pereira: Bicarbonate-mediated signalling phosphorylates Hsp70 into a potent amyloid disaggregase

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 12. Please feel free to provide constructive comments for Lionel

Question Title

* 13. Negin Imani Farahani : Investigating the utility of iPSC-derived choroid plexus organoids to yield fluid biomarkers in SCA1 disease modeling

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 14. Please feel free to provide constructive comments for Negin

Question Title

* 15. Josh Ham: The Vesicular Nucleotide Transporter: What Makes ATP Neurotransmission Different?

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 16. Please feel free to provide constructive comments for Josh

Question Title

* 17. Diana Hunter: Manipulating Matrix Shape and Stiffness for patch clamp studies of iPSC derived cardiomyocytes

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 18. Please feel free to provide constructive comments for Diana

Question Title

* 19. Kosar Jabbari : Advancing Cardiac Disease Research: Automated Stem Cell Culture and Data-Driven Approaches.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 20. Please feel free to provide constructive comments for Kosar

Question Title

* 21. Mariam Butt : Investigating the Impact of LQT2-Linked KCNH2 Variant T65P in a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 22. Please feel free to provide constructive comments for Mariam

Question Title

* 23. Alia Arslanova: Investigating the Pathogenicity of RYR2 Exon 3 Deletion Variant Using a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 24. Please feel free to provide constructive comments for Alia

Question Title

* 25. Dina Hosseini Baygi : A Biological Perception into Microtubules in Hypertrophic Cardiomyopathy associated Troponin-T (TNNT2) variants using Human-induced Pluripotent Stem Cells derived Cardiomyocyte

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 26. Please feel free to provide constructive comments for Dina

Question Title

* 27. Hosna Babini: Impact of the atrial fibrillation (AF) associated KCNN3 rs13376333 risk variant on SK-current density in hiPSC-aCMs

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 28. Please feel free to provide constructive comments for Hosna

Question Title

* 29. Jessica Felix: Investigating Autophagy-related Cysteine Protease Atg4a in Drosophila melanogaster Models of Cancer

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 30. Please feel free to provide constructive comments for Jessica

Question Title

* 31. Brandon Fonseca : Investigating the role of Mac-1 catch-bonds in macrophage

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 32. Please feel free to provide constructive comments for Brandon

Question Title

* 33. Gurpreet Moroak : Nutrient sensor Salt-inducible Kinase synergizes with Homeodomain-interacting Protein Kinase to promote cancer cachexia in a Drosophila tumor model

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 34. Please feel free to provide constructive comments for Gurpreet

Question Title

* 35. Rasool Khaef Panah : Deciphering the role of Mac-1 receptor during Rituximab mediated phagocytosis of B-cell lymphomas

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 36. Please feel free to provide constructive comments for Rasool

Question Title

* 37. Krysta Coyle : Genomic instability is a feature of mantle cell lymphoma

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 38. Please feel free to provide constructive comments for Krysta